Abiopharma

🔍 Hemhauser Maureen (Executive)

Company: PEAPACK GLADSTONE FINANCIAL CORP (PGC)

Report Date: 2026-03-20

Detailed Transactions and Holdings:

• Acquired 699 shares of Common Stock (Direct)
  Date: 2026-03-20 | Code: M | equity_swap_involved: false | shares_owned_after: 699.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 220 shares of Common Stock at $33.18 per share (Direct)
  Date: 2026-03-20 | Code: F | equity_swap_involved: false | shares_owned_after: 479.00 | transaction_form_type: 4 | Footnotes: F2
• Acquired 1,232 shares of Common Stock (Direct)
  Date: 2026-03-20 | Code: M | equity_swap_involved: false | shares_owned_after: 1,711.00 | transaction_form_type: 4 | Footnotes: F3
• Sold 387 shares of Common Stock at $33.18 per share (Direct)
  Date: 2026-03-20 | Code: F | equity_swap_involved: false | shares_owned_after: 1,324.00 | transaction_form_type: 4 | Footnotes: F2
• Acquired 1,418 shares of Common Stock (Direct)
  Date: 2026-03-20 | Code: M | equity_swap_involved: false | shares_owned_after: 2,742.00 | transaction_form_type: 4 | Footnotes: F4
• Sold 445 shares of Common Stock at $33.18 per share (Direct)
  Date: 2026-03-20 | Code: F | equity_swap_involved: false | shares_owned_after: 2,297.00 | transaction_form_type: 4 | Footnotes: F2
• Acquired 699 shares of Common Stock (Direct)
  Date: 2026-03-20 | Code: M | equity_swap_involved: false | shares_owned_after: 8,638.00 | transaction_form_type: 4 | Footnotes: F1, F5
• Acquired 942 shares of Common Stock (Direct)
  Date: 2026-03-20 | Code: M | equity_swap_involved: false | shares_owned_after: 9,580.00 | transaction_form_type: 4 | Footnotes: F6, F5
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-03-20 | Code: H | nature_of_ownership: 401(k) | shares_owned_after: 456.11
• Sold 1,398 shares of Restricted Stock Units (Derivative)
  Date: 2026-03-20 | Code: M | equity_swap_involved: false | shares_owned_after: 2,799.00 | transaction_form_type: 4 | Footnotes: F1, F1, F1, F1
• Acquired 5,386 shares of Restricted Stock Units (Derivative)
  Date: 2026-03-20 | Code: A | equity_swap_involved: false | shares_owned_after: 5,386.00 | transaction_form_type: 4 | Footnotes: F7, F7, F7, F7
• Sold 942 shares of Restricted Stock Units (Derivative)
  Date: 2026-03-20 | Code: M | equity_swap_involved: false | shares_owned_after: 944.00 | transaction_form_type: 4 | Footnotes: F6, F6, F6, F6
• Sold 1,232 shares of Restricted Stock Units (Derivative)
  Date: 2026-03-20 | Code: M | equity_swap_involved: false | shares_owned_after: 2,466.00 | transaction_form_type: 4 | Footnotes: F3, F3, F3, F3
• Sold 1,418 shares of Restricted Stock Units (Derivative)
  Date: 2026-03-20 | Code: M | equity_swap_involved: false | transaction_form_type: 4 | Footnotes: F4, F4, F4, F4
• Acquired 1,795 shares of Restricted Stock Units (Derivative)
  Date: 2026-03-20 | Code: A | equity_swap_involved: false | shares_owned_after: 1,795.00 | transaction_form_type: 4 | Footnotes: F9, F9, F9, F9
• Sold 1,426 shares of Phantom Stock (Derivative)
  Date: 2026-03-20 | Code: M | equity_swap_involved: false | shares_owned_after: 1,427.00 | transaction_form_type: 4 | Footnotes: F10, F10, F10, F10
• Sold 660 shares of Phantom Stock (Derivative)
  Date: 2026-03-20 | Code: M | equity_swap_involved: false | transaction_form_type: 4 | Footnotes: F11, F11, F11, F11
• Holds 1,399 shares of Restriced Stock Units (Derivative)
  Date: 2026-03-20 | Code: H | shares_owned_after: 1,399.00 | Footnotes: F8, F8, F8
• Holds 1,426 shares of Phantom Stock Units (Derivative)
  Date: 2026-03-20 | Code: H | shares_owned_after: 1,426.00 | Footnotes: F12, F12, F12

Footnotes:

• F1: On March 20, 2025, the reporting person was granted 4,197 restricted stock units (RSUs), vesting in three equal annual installments beginning on March 20, 2026. Upon vesting, each RSU converts into one share of PGC common stock.
• F2: Shares withheld to satisfy tax withholding obligations arising from settlement of restricted stock units.
• F3: On March 20, 2023, the reporting person was granted 6,162 restricted stock units (RSUs), vesting in five equal annual installments beginning on March 20, 2024. Upon vesting, each RSU converts into one share of PGC common stock.
• F4: On March 20, 2023, the reporting person was granted 2,054 restricted stock units (RSUs), vesting on the third anniversary of the grant if certain performance conditions are met. Upon vesting, each RSU converts into one share of PGC common stock. 1,418 restricted stock units vested.
• F5: Held indirectly through a rabbi trust pursuant to a non-qualified deferred compensation plan.
• F6: On March 20, 2022, the reporting person was granted 4,712 restricted stock units (RSUs), vesting in five equal annual installments beginning on March 20, 2023. Upon vesting, each RSU converts into one share of PGC common stock.
• F7: On March 20, 2026, the reporting person was granted 5,386 restricted stock units (RSUs), vesting in three equal annual installments beginning on March 20, 2027. Upon vesting, each RSU converts into one share of PGC common stock.
• F8: On March 20, 2025, the reporting person was granted 1,399 restricted stock units (RSUs), vesting on the third anniversary of the grant if certain performance conditions are met. Upon vesting, each RSU converts into one share of PGC common stock.
• F9: On March 20, 2026, the reporting person was granted 1,795 restricted stock units (RSUs), vesting on the third anniversary of the grant if certain performance conditions are met. Upon vesting, each RSU converts into one share of PGC common stock.
• F10: On March 20, 2024, the reporting person was granted 4,279 phantom stock shares, vesting in three equal annual installments beginning on March 20, 2025. Upon vesting, each phantom share is the economic equivalent of one share of common stock.
• F11: On March 20, 2021, the reporting person was granted 3,287 phantom stock shares, vesting in five equal annual installments beginning on March 20, 2022. Upon vesting, each phantom share is the economic equivalent of one share of common stock.
• F12: On March 20, 2024, the reporting person was granted 1,426 phantom stock shares, vesting on the third anniversary of the grant if certain performance conditions are met. Upon vesting, each phantom share is the economic equivalent of one share of common stock.